Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2009-09-28
Original market date: See footnote 1
2001-12-19
Product name:
REPLAVITE
DIN:
02244872 Electronic product monograph is not available
Company:
WN PHARMACEUTICALS LTD.
2000 Brigantine Drive
Coquitlam
British Columbia
Canada
V3K 7B5
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
9
Schedule(s):
NON-PRESCRIPTION DRUGS
Anatomical Therapeutic Chemical (ATC): See footnote 4
A11EB VITAMIN B-COMPLEX WITH VITAMIN C
Active ingredient group (AIG) number:See footnote5
0914845005
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| ASCORBIC ACID (ASCORBIC ACID) | 100 MG |
| BIOTIN | 300 MCG |
| D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) | 10 MG |
| FOLIC ACID | 1 MG |
| NICOTINAMIDE | 20 MG |
| VITAMIN B1 (THIAMINE MONONITRATE) | 1.5 MG |
| VITAMIN B12 (VITAMIN B12) | 6 MCG |
| VITAMIN B2 (VITAMIN B2) | 1.7 MG |
| VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) | 10 MG |